Top Tweets for #DUPIXENT
🔬 #EosinophilicGastritis has a substantial impact on quality of life but no FDA-approved therapy.
In a phase 2 trial published in @LanceGastroHep, #Dupixent @Regeneron @sanofi improved:
✅Inflammation
✅Endoscopic and histological measures https://t.co/SAUlYqYI7x
🗨️ A “growing body of evidence” suggests #EosinophilicGastritis is a type 2 inflammatory disease, said Dr. Marc E. Rothenberg @CincyChildrens.
💉 #Dupixent @Regeneron @sanofi improved #inflammation in patients with EoG, study results show. https://t.co/DvraXuLiuH
top 13 pharma by enterprise value
El @CIMP propone la financiación de los nuevos tratamientos biológicos de la #EPOC, el #DUPIXENT Y #NUCALA.
Entendemos que los múltiples reuniones, escritos, etc de @apepoc_es finalmente han surtido efecto!!
Otro logro más para nuestra comunidad respiratoria y #APEPOC!!!
Did you miss this from the floor at #DDW2026?
🔥 @sanofi & @Regeneron’s #Dupixent didn’t just calm #EoE inflammation, but improved esophageal diameter with gains rivaling a dilation session 🫢 https://t.co/B9QjfsRM3q
Eupraxia, Dupixent, and the Race to Redefine EoE Care -( $EPRX $REGN $SNY )
https://t.co/IrrObfXpQM
#Eupraxia #EPRX #Dupixent #REGN #Sanofi #SNY #EoE #EosinophilicEsophagitis #GI #BiotechStocks #BiotechInvesting #DrugDelivery #DiffuSphere #RareDisease #Immunology #HealthCare
Eupraxia, Dupixent, and the Race to Redefine EoE Care -( $EPRX $REGN $SNY )
https://t.co/06xpOQlPlX
#Eupraxia #EPRX #Dupixent #REGN #Sanofi #SNY #EoE #EosinophilicEsophagitis #GI #BiotechStocks #BiotechInvesting #DrugDelivery #DiffuSphere #EP104GI #Gastroenterology $IBB $XBI
Aprueban tratamiento dirigido para niños con #urticariacrónicaespontánea Con esta decisión, #Dupixent se convierte en el primer tratamiento biológico aprobado para #niños desde los dos años de edad con esta condición. https://t.co/9fG5wx0365
Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges
#Dupixent #CTCL #EczemaMedication
https://t.co/6zLKa7noBw
Dupi whoopie: @sanofi/@Regeneron cheered for sales, new #approval https://t.co/SiqVtYmIxw #biopharma #Dupixent #urticaria
$SNY #Sanofi double-digit sales and business EPS growth. What would the pharmaceutical company be without Dupi? $REGN https://t.co/POv4T5AteL
🚨 FDA UPDATE: The FDA has approved dupilumab for chronic spontaneous urticaria in children as young as 2 — the first biologic ever cleared for this age group in the US. https://t.co/p3AkQnHh1Q #Dermatology #CSU #Dupilumab #Dupixent #PediatricDerm #FDAApproval
Positive-Sum Correlation
Atopic Dermatitis Bio Basket strong day
UP 3.3% v $XBI 0.9%
Strong investor interest in fast growing indication due to $SNY LOE for $20B #Dupixent starting in 2030
Potential successors w/ novel MOA or next-gen approach
$ACRS $APGE $CRVS $EVMN $KYMR $NKTR
EW Basket of (6) Atopic Dermatitis Bios Strongly Outperforming $XBI
46% v 7.4% (YTD 2026)
$ACRS $APGE $CRVS $EVMN $KYMR $NKTR
Combination of $SNY challenges finding a #Dupixent successsor and strong AD data from these bios over past few months
Positive-Sum Correlation At Work
EW Basket of (6) Atopic Dermatitis Bios Strongly Outperforming $XBI
46% v 7.4% (YTD 2026)
$ACRS $APGE $CRVS $EVMN $KYMR $NKTR
Combination of $SNY challenges finding a #Dupixent successsor and strong AD data from these bios over past few months
Positive-Sum Correlation At Work
Atopic Dermatis bios displaying Positive-Sum Correlation over last 3 yrs, accelerated post key data in last 12 months⤵️
Broad set of winners increases partnering and M&A potential for entire group
$ACRS $AMGN $ACRS $CRVS $KYMR $JNJ $LLY $NKTR $PFE $REGN $SNY $TAK
Dupilumab Increases Risk of Conjunctivitis, Blepharitis in Children
This population may be vulnerable to heightened immune responses and immature goblet cells caused by IL-4 suppression.
https://t.co/OHtRnqPT4S
#dupixent #optometry #eyecare
Using $ERAS model $CRVS should move much higer post raise
$CRVS MC still $1.8Bn for an oral pill better than #Dupixent $REGN $SNY w/ Ph2a trial design
Corvus pipeline more advanced as #ITK inhibitor #soquelitinib is in Ph3 trial for #PTCL
$ERAS doubled on data on Jan 12 to $6 then continued to rise another 70% over 10 days before pricing their raise.
- $2.8Bn MC for a Ph1 asset
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.5M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.7M followers
KATY PERRY
@katyperry
89.5M followers
Taylor Swift
@taylorswift13
83.4M followers
Lady Gaga
@ladygaga
74.9M followers
Virat Kohli
@imvkohli
72.6M followers
Kim Kardashian
@kimkardashian
70.7M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65.6M followers
Bill Gates
@billgates
64.8M followers
Selena Gomez
@selenagomez
62.6M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers